TARDBP and amyotrophic lateral sclerosis: Further studies are clearly needed to understand the mechanism of pathological TDP-43 and the ambiguous role of lipocalin-2 in ALS and FTD pathogenesis and its potential as a therapeutic target or biomarker for assessing neuroinflammation.